Literature DB >> 2503514

Proalbumin to albumin conversion by a proinsulin processing endopeptidase of insulin secretory granules.

C J Rhodes1, S O Brennan, J C Hutton.   

Abstract

A lysate of purified insulin secretory granules, which contains two types of proinsulin processing activity (type 1, Arg-Arg-directed and type II, Lys-Arg-directed (Davidson, H.W., Rhodes, C.J., and Hutton, J. C. (1988) Nature 333, 93-96), was found to process proalbumin by specific proteolytic cleavage of the COOH-terminal side of the Arg-2-Arg-1 sequence. The subcellular distribution of proalbumin processing activity in insulinoma tissue paralleled that for proinsulin conversion and occurred principally in a secretory granule fraction. Cleavage appeared to result from the Arg-Arg-directed type 1 proinsulin processing endo-peptidase. It was Ca2+-dependent (K0.5 activation = 1.0-1.5 mM Ca2+), unaffected by group-specific inhibitors of serine, cysteinyl, or aspartyl proteinases, and had an acidic pH optimum (5.5). Active-site inhibitor studies showed this activity had a preference for dibasic over monobasic amino acid sequences and indicated that the sequence of the dibasic site was an important determinant of the susceptibility of the substrate to cleavage. The activity did not process the proalbumin Christchurch mutant (Arg-2-Arg-1 to Arg-2-Gln-1). It was inhibited by the variant alpha 1-antitrypsin Pittsburgh (Met358 to Arg358; K0.5 = 100 nM) but not by other related proteins normally co-secreted with albumin from hepatocytes, namely alpha 1-antitrypsin M, alpha 2-macroglobulin, or antithrombin III. The insulin secretory granule proalbumin processing activity was indistinguishable from a proalbumin endopeptidase reported in rat liver membranes and similar to the yeast KEX-2 protease. These findings suggest that a highly conserved set of proprotein endopeptidases exists, which are specific for a dibasic sequence but broadly specific for proprotein substrates. Such enzymic activities appear to be active within both the constitutive and regulated pathways of secretion. Intraorganellar Ca2+ and pH appear to play a key role in regulating their activities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503514

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  The enzymology of proinsulin conversion.

Authors:  J C Hutton; C J Rhodes
Journal:  Cell Biophys       Date:  1991 Oct-Dec

2.  Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.

Authors:  Israr-Ul H Ansari; Melissa J Longacre; Scott W Stoker; Mindy A Kendrick; Lucas M O'Neill; Laura J Zitur; Luis A Fernandez; James M Ntambi; Michael J MacDonald
Journal:  Arch Biochem Biophys       Date:  2017-02-11       Impact factor: 4.013

3.  Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells.

Authors:  Domenico Bosco; Paolo Meda; Philippe Morel; David Matthey-Doret; Dorothée Caille; Christian Toso; Leo H Bühler; Thierry Berney
Journal:  Diabetologia       Date:  2005-07-07       Impact factor: 10.122

4.  Tamoxifen inhibits acidification in cells independent of the estrogen receptor.

Authors:  N Altan; Y Chen; M Schindler; S M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase.

Authors:  E M Bailyes; K I Shennan; A J Seal; S P Smeekens; D F Steiner; J C Hutton; K Docherty
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

6.  A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor.

Authors:  C Alarcón; B Cheatham; B Lincoln; C R Kahn; K Siddle; C J Rhodes
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

7.  Characterization of phospholipids in insulin secretory granules and mitochondria in pancreatic beta cells and their changes with glucose stimulation.

Authors:  Michael J MacDonald; Lacmbouh Ade; James M Ntambi; Israr-Ul H Ansari; Scott W Stoker
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

8.  A novel regulatory mechanism for trimeric GTP-binding proteins in the membrane and secretory granule fractions of human and rodent beta cells.

Authors:  A Kowluru; S E Seavey; C J Rhodes; S A Metz
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  Processing of proopiomelanocortin by insulin secretory granule proinsulin processing endopeptidases.

Authors:  C J Rhodes; B A Thorne; B Lincoln; E Nielsen; J C Hutton; G Thomas
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

10.  Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells: THEIR GENE SILENCING INHIBITS INSULIN SECRETION.

Authors:  Israr-ul H Ansari; Melissa J Longacre; Coen C Paulusma; Scott W Stoker; Mindy A Kendrick; Michael J MacDonald
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.